Ovarian Cancer

Longitudinal MicroRNAs Lacked Predictive Value in Ovarian Cancer

By

Leah Lawrence

Publish Date July 30, 2020

Study results differ from prior research into microRNAs as predictive biomarkers.

Study Suggests QoL Assessments Do Not Support First-Line Combination Chemotherapy With Weekly Paclitaxel for Epithelial Ovarian Cancer

By

Susan Moench, PhD, PA-C

Publish Date July 28, 2020

This analysis focused on QoL end points associated with different dosing schedules for first-line carboplatin-paclitaxel in a predominantly European population with EOC.

Bowel Procedure During Ovarian Surgery Linked to Higher Odds of Surgical Infection

By

Christina Bennett, MS

Publish Date July 16, 2020

The odds of developing a surgical infection after cytoreductive surgery for ovarian cancer more than doubled in women who had bowel resection or repair.

Guidance for the Diagnosis and Management of Ovarian Cysts

By

Meaghan Mize, PA-C

Alicia Elam, PharmD

Publish Date July 3, 2020

The risk of developing benign ovarian cysts is up to 90% for premenopausal women and 75% for postmenopausal women.

TP53 Mutations Present in HPV-Negative Vulvar Cancer

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date July 2, 2020

In a whole-exome analysis, the most common mutations occurred in TP53, and mutations in other known cancer-associated genes were identified in women with HPV-negative vulvar cancer.

Ovarian Cancer Clinical Trials

Clinical Trial: Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Clinical Trial: Prophylactic Salpingectomy With Delayed Oophorectomy

Clinical Trial: Interactive Educational Website for Women With Ovarian Cancer & Caregivers

Clinical Trial: Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status

Clinical Trial: AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer